🪙 Altcoins: Injective News

Pineapple Financial’s recent deployment of $1 billion in mortgage-backed tokens on Injective highlights the protocol’s growing role as a liquidity conduit for institutional asset‑backed derivatives. The move follows a prior $10 billion mortgage loan re‑allocation, signaling confidence in Injective’s cross‑chain order‑book architecture and its ability to support large, off‑chain collateral. Market participants are watching how this influx of stable‑asset collateral may affect on‑chain liquidity, fee revenue, and the depth of the order book, potentially driving higher trading volumes and tighter spreads. Injective’s 5 % price decline amid a reported exploit and an Upbit warning underscores heightened security concerns for DeFi platforms. The exploit, though not yet quantified, could erode trust and prompt a temporary liquidity drain, especially from retail traders who favor the platform’s low‑fee, high‑speed trades. Regulatory scrutiny may intensify, particularly in jurisdictions wary of cross‑border derivative exposure, potentially leading to tighter oversight or capital‑requirement adjustments for institutional users.